Search research articles
Contact Us
Filters
Showing results (111-120 of 138) with videos related to
Page
of 14
Sort By:
Journal of the National Cancer Institute
|
November 6, 2003
Magnetic resonance spectroscopic pharmacodynamic markers of the heat shock protein 90 inhibitor 17-allylamino,17-demethoxygeldanamycin (17AAG) in human colon cancer models
Yuen-Li Chung, Helen Troy, Udai Banerji, et al.
Anticancer Research
|
July 1, 1996
The activity of N-(hydroxymethyl) melamines in fresh human ovarian tumour cells and xenografts
H M Coley, M Jarman, M Jones, et al.
NCI Monographs : a Publication of the National Cancer Institute
|
January 1, 1987
Recent preclinical and clinical studies with the thymidylate synthase inhibitor N10-propargyl-5,8-dideazafolic acid (CB 3717)
A H Calvert, D R Newell, A L Jackman, et al.
Cancer
|
May 13, 2022
First-line chemotherapy in advanced intra-abdominal well-differentiated/dedifferentiated liposarcoma: An EORTC Soft Tissue and Bone Sarcoma Group retrospective analysis
Silvia Stacchiotti, Winette T A Van der Graaf, Roberta G Sanfilippo, et al.
Anticancer Research
|
October 1, 2021
Treatments and Outcomes in Oligometastatic Soft Tissue Soft Sarcoma - A Single Centre Retrospective Analysis
Gerard M Walls, Shane H Zaidi, Nicos Fotiadis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1996
Phase I trial of ZD1694, a new folate-based thymidylate synthase inhibitor, in patients with solid tumors
S J Clarke, J Hanwell, M de Boer, et al.
Medical Oncology (Northwood, London, England)
|
April 15, 2010
Chemotherapy in clear cell sarcoma
Robin L Jones, Anastasia Constantinidou, Khin Thway, et al.
Cancer Chemotherapy and Pharmacology
|
December 14, 2004
Investigations in vivo of the effects of carbogen breathing on 5-fluorouracil pharmacokinetics and physiology of solid rodent tumours
P M J McSheehy, R E Port, L M Rodrigues, et al.
Cancer Research
|
January 7, 2006
Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of the choline kinase inhibitor MN58b in human carcinoma models
Nada M S Al-Saffar, Helen Troy, Ana Ramírez de Molina, et al.
British Journal of Cancer
|
September 8, 2023
Axitinib in patients with advanced/metastatic soft tissue sarcoma (Axi-STS): an open-label, multicentre, phase II trial in four histological strata
Penella J Woll, Piers Gaunt, Charlotte Gaskell, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 138) with videos related to
Sort By:
Page
of 14
Journal of the National Cancer Institute
|
November 6, 2003
Magnetic resonance spectroscopic pharmacodynamic markers of the heat shock protein 90 inhibitor 17-allylamino,17-demethoxygeldanamycin (17AAG) in human colon cancer models
Yuen-Li Chung, Helen Troy, Udai Banerji, et al.
Anticancer Research
|
July 1, 1996
The activity of N-(hydroxymethyl) melamines in fresh human ovarian tumour cells and xenografts
H M Coley, M Jarman, M Jones, et al.
NCI Monographs : a Publication of the National Cancer Institute
|
January 1, 1987
Recent preclinical and clinical studies with the thymidylate synthase inhibitor N10-propargyl-5,8-dideazafolic acid (CB 3717)
A H Calvert, D R Newell, A L Jackman, et al.
Cancer
|
May 13, 2022
First-line chemotherapy in advanced intra-abdominal well-differentiated/dedifferentiated liposarcoma: An EORTC Soft Tissue and Bone Sarcoma Group retrospective analysis
Silvia Stacchiotti, Winette T A Van der Graaf, Roberta G Sanfilippo, et al.
Anticancer Research
|
October 1, 2021
Treatments and Outcomes in Oligometastatic Soft Tissue Soft Sarcoma - A Single Centre Retrospective Analysis
Gerard M Walls, Shane H Zaidi, Nicos Fotiadis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1996
Phase I trial of ZD1694, a new folate-based thymidylate synthase inhibitor, in patients with solid tumors
S J Clarke, J Hanwell, M de Boer, et al.
Medical Oncology (Northwood, London, England)
|
April 15, 2010
Chemotherapy in clear cell sarcoma
Robin L Jones, Anastasia Constantinidou, Khin Thway, et al.
Cancer Chemotherapy and Pharmacology
|
December 14, 2004
Investigations in vivo of the effects of carbogen breathing on 5-fluorouracil pharmacokinetics and physiology of solid rodent tumours
P M J McSheehy, R E Port, L M Rodrigues, et al.
Cancer Research
|
January 7, 2006
Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of the choline kinase inhibitor MN58b in human carcinoma models
Nada M S Al-Saffar, Helen Troy, Ana Ramírez de Molina, et al.
British Journal of Cancer
|
September 8, 2023
Axitinib in patients with advanced/metastatic soft tissue sarcoma (Axi-STS): an open-label, multicentre, phase II trial in four histological strata
Penella J Woll, Piers Gaunt, Charlotte Gaskell, et al.
Page
of 14